Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Adrenal Cortex Neoplasms
Welcome,
Profile
Billing
Logout
18 Companies
21 Products
21 Products
21 Mechanisms of Action
1 Trial
51 News
«
1
2
||||||||||
dovitinib
(TKI258) /
Novartis, Oncoheroes
New P2 trial, Metastases:
Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma
(clinicaltrials.gov) - Jan 19, 2012
P2
, N=17, Active, not recruiting,
Sponsor: Spanish Oncology Genito-Urinary Group